CUV 1.85% $13.28 clinuvel pharmaceuticals limited

FDA update, page-4

  1. 693 Posts.
    lightbulb Created with Sketch. 317
    That is exactly what many have been thinking for 10 years or more!! I also expect that is one of the reasons why there is so little retail interest in this company. The truth is to go from phase 1 to profitability (not quite there yet) in 10 years, spending only 100million is actually quite respectable. It is just a very tough road for investors, waiting for so long with so much risk.

    Still with sales to half of the worlds EPP population soon to commence and 2 very large fund managers buying all the shares on market there can't be a lot of downside from here. Surely?
    Last edited by cuv101: 06/02/16
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.28
Change
-0.250(1.85%)
Mkt cap ! $664.8M
Open High Low Value Volume
$13.55 $13.62 $13.25 $1.157M 86.45K

Buyers (Bids)

No. Vol. Price($)
1 227 $13.28
 

Sellers (Offers)

Price($) Vol. No.
$13.42 228 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.